The first randomized controlled trial1,2 to assess the effectiveness of surgical face masks against SARS-CoV-2 infection specifically — which journals initially refused to publish — is finally seeing the light of day. The so-called “Danmask-19 Trial,” published November 18, 2020, in the Annals of Internal Medicine,3 included 3,030 individuals assigned to wear a surgical face… Read More »
Exposure to child care was not associated with a heightened risk of coronavirus infection for providers, according to what authors say is the largest study of its kind. Researchers from Yale University gathered data from over 57,000 child care providers in the U.S. amid the first several months in the pandemic to assess for an… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »